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Peripheral joint osteoarthritis (OA) is predominantly a clinical diagnosis, though imaging may provide
conﬁrmation and aid with differential diagnosis where there is clinical doubt. Whilst radiographs (X-rays
(XR)) are usually the ﬁrst-line imaging modality selected, magnetic resonance imaging (MRI), ultrasound
and computed tomography (CT) may all have a valuable role in assessing a personwith OA, although each
has its particular advantages and disadvantages. MRI is of particular use for diagnosing bone conditions
that may cause a rapid increase in symptoms, such as avascular necrosis (AVN) or a subchondral
insufﬁciency fracture (SIF), while providing concomitant soft tissue assessment. Ultrasound offers rapid
assessment of peripheral joints and can easily assess for features of inﬂammatory arthritis. CT is faster to
perform than MRI and can also image the subchondral bone, but does involve ionising radiation.
Selecting the correct imaging modality, in the context of its advantages when visualising a speciﬁc joint
(e.g., hand vs knee) and with clinical context in mind, will enhance the added value of imaging in clinical
practice.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction Utility of imaging in the diagnosis of peripheral joint OAWhilst the diagnosis of osteoarthritis (OA) is usually made
clinically, imagingmay be used to conﬁrm the diagnosis or examine
alternative diagnoses when there is clinical doubt. This review aims
to discuss the application of widely available imaging modalities
including radiographs, ultrasound, magnetic resonance imaging
(MRI) and computed tomography (CT) in clinical practice, both in
the diagnosis and monitoring of OA and when assessing other
conditions which may occur concomitantly or as a differential
diagnosis of OA. Such conditions included in this review include
rapidly progressive OA, avascular necrosis (AVN) of the femoral
head, subchondral insufﬁciency fractures (SIF), calcium pyrophos-
phate deposition (CPPD) and gout. The role of imaging to help
differentiate between OA and inﬂammatory arthritis is also
discussed..Y.J. Wenham, Leeds Institute
ity of Leeds, Chapel Allerton
enham).
ternational. Published by Elsevier LA number of commonly used imaging modalities may have a
diagnostic role in clinical practice: plain radiographs (X-rays (XR)),
ultrasound and MRI. CT may also be considered in settings where
MRI is not available. Imaging is not usually required for the diagnosis
of OA and should be used where there is doubt over the clinical
diagnosis or to exclude a differential diagnosis. While XRs remain
the cheapest, easiest and ﬁrst-line choice for imaging examination
in suspected OA, the American College of Rheumatology (ACR)1, the
UK National Institute for Health and Clinical Excellence (NICE)2 and
the European League Against Rheumatism (EULAR)3 support the
clinical diagnosis of knee OA based on clinical symptoms and ex-
amination ﬁndings, without requiring an XR. Recent EULAR rec-
ommendations also acknowledged that thediagnosis of kneeOAcan
be made in the presence of speciﬁc clinical and examination fea-
tures, even if a radiograph appears normal3. It is important to realise
that the added value that an imaging modality brings to diagnosis
depends on the pre-test probability of a speciﬁc diagnosis.
Radiographs in the diagnosis of OA
Studies comparing radiological with clinical criteria for the
diagnosis of OA knee have shown a wide range of sensitivities andtd. All rights reserved.
Fig. 1. Fat suppressed, proton density MRI of the knee (coronal view) demonstrating
bone marrow lesions (arrowed). Note also the macerated medial meniscus and medial
osteophytes.
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pathological changes seen in OA6 and therefore may appear
normal7. Furthermore, even among expert readers, the degree of
reported osteophytosis and joint space narrowing (JSN) may be
variable8. A systematic review noted agreement between radio-
logical and clinical diagnosis in only 4/39 studies assessed, there
was no agreement in 7/39 studies and inconsistent agreement in
the remainder9. Furthermore, due to the projectional nature of XR,
the radiographic diagnosis of OA depends on the XR view used,
with the likelihood of a diagnosis of knee OA increasing with the
number of XR views used10. Using a posteroanterior (PA) viewalone
(the standard view requested by most non-specialist clinicians, for
example primary care doctors) identiﬁes only 56% of cases of
radiographic OA, adding a skyline or lateral view increased the
identiﬁcation to 87%, and all three views increases identiﬁcation to
almost 100%. Hence requesting a PA knee XR is not necessary to
conﬁrm the diagnosis of OA in a person fulﬁlling clinical criteria for
OA but should be used in the correct clinical context to conﬁrm
other diagnoses, for example, if there is a history of trauma (to
diagnose potential fracture), if the person's symptoms suggest in-
ﬂammatory arthritis, or if an alternate diagnosis is probable.
With regards to hand OA, the ACR criteria for classiﬁcation of
hand OA note that physical examination has been shown to be
more sensitive and speciﬁc than XRs for diagnosing symptomatic
hand OA11. However, XRs remain the current validated principal
imaging technique to examine the morphological changes of hand
OA12. Classic individual radiographic features such as JSN and
osteophytes are sensitive for the diagnosis of OA and the presence
of more than one radiographic feature of OA (JSN, osteophytes,
subchondral bone cysts and sclerosis), particularly if combined
with typical clinical features, strongly increases diagnostic cer-
tainty12. EULAR recommends that further diagnostic imaging is
seldom needed to conﬁrm a diagnosis of hand OA12. In clinical
practice, if a patient presents with an abrupt onset of interpha-
langeal joint pain and functional loss with inﬂammatory symp-
toms, performing a hand XR to assess for erosive OA, which can
present in such a way and may have a worse outcome than non-
erosive hand OA, may be of help in conﬁrming the diagnosis12.
There are no international guidelines for the diagnosis of hip OA,
but the ACR classiﬁcation criteria has demonstrated that the
radiographic presence of osteophytes is both sensitive and speciﬁc
to hip OA11. In clinical practice, although examination features such
as reduction of internal rotation and hip pain (usually felt in the
groin or deep buttock) may allow the clinician to diagnose hip OA
with conﬁdence11, an XR is often helpful to conﬁrm the diagnosis
and in particular to exclude other diagnoses.
Ultrasound in the diagnosis of OA
Ultrasound avoids radiation and is comfortable and convenient
for the patient but requires a skilled operator. US can assess most
peripheral OA joint pathologies depending on its acoustic window:
it can visualise synovial hypertrophy and inﬂammation (using both
grey scale and power Doppler techniques), osteophytes, cartilage
(near the joint surface) and the superﬁcial components of the
menisci (including detecting extrusion) in the knee. Ultrasound
detects more osteophytes in OA hand joints than XR, especially at
the metacarpophalangeal joints13. Ultrasound cannot assess sub-
chondral bone lesions such as cysts, and the ﬁndings may vary
depending on joint positioning14. Ultrasound imaging requires a
skilled operator as the ﬁndings may be operator-dependent, for
example, the thickness of measured cartilage may depend on the
angle with which the transducer is held.
A systematic review assessing the relationship between ultra-
sound ﬁndings and a clinical diagnosis of OA included 47 studiesincluding OA of the knee, hand, hip and foot and noted that there
was no consistent relationship between clinical diagnosis and ul-
trasound-detected pathology15. This review did note that several of
the included papers did not have a clear deﬁnition of clinical OA
and where it was included, the deﬁnition of OA was not consistent
across studies. Ongoing development of accepted ultrasound deﬁ-
nition of OA will improve consistency across studies, aiding both
clinical diagnosis of OA and offering potential for monitoring both
disease progression and response to treatment16. Ultrasound can be
very helpful in the clinic in the differential diagnosis of painful
joints, for example, detection of widespread Power Doppler posi-
tive synovitis with erosions would add weight to a diagnosis of
inﬂammatory arthritis in the hands, or the presence of meniscal
extrusion and cyst with JSN in a swollen knee may favour a diag-
nosis of OA.
MRI in the diagnosis of OA
MRI offers superb soft tissue contrast in a tomographic pre-
sentation and has the advantage over XR or ultrasound of visual-
ising all the structures within a joint, including the subchondral
bone (Fig. 1). As mentioned, MRI can detect structural change when
the XR is normal7. MRI detection of synovitis (Fig. 2) is improved
with intravenous contrast by enabling differentiation from joint
effusion17, however such contrast agents require intravenous ac-
cess, have very small risks of sensitivity reactions and are associ-
ated with rare side effects such as nephrogenic ﬁbrosis18. In
practice, it is common to get useful and diagnostic information on
the extent of soft tissue and bone pathologies using non-contrast
MRI; when speciﬁc synovitis sequences are needed it is worth
involving a radiologist.
Fig. 2. Contrast enhanced, fat suppressed MRI of the knee (axial view) demonstrating
extensive synovitis (solid arrows) and osteophytes (dotted arrows).
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OA19,20. One noted that using MR imaging did not increase the
diagnosis of OA if clinical features of OA were present prior to im-
aging20. The other noted no consistent association between clinical
assessment andMRI abnormalities, other than for a joint effusion19.
A large study of 710 people, mean age 62 years and with no
radiographic evidence of knee OA underwent MRI and were strat-
iﬁed by symptoms. 89% had MR changes compatible with OA. The
presence of at least one type of pathology was high in both painful
(up to 97%) and painless knees (up to 88%)7. Hence MRI features of
OA are highly prevalent in the older population even without knee
pain and in clinical practice, an MRI scan should be requested only
to answer a speciﬁc question in a person with clinical OA, for
example to detect ameniscal tear that maywarrant surgical referral
in a patient who reports true locking of the knee joint (as opposed
to complaints of pseudo-locking or gelling). There are preliminary
MRI diagnostic criteria for OA, for use in the research setting only,
and may be used in future to stratify patients for clinical trials21.
While the literature on use of MRI to assess hand OA is slowly
growing, it remains a research tool at present, providing greater
understanding of structure-pain relationships and giving insights
into the progression of structural changes22 (including recent in-
formation on the relationship between inﬂammation and erosive
OA).
A full history, clinical examination and anteroposterior XR of the
affected hip should be the ﬁrst-line choice of imaging to diagnose
the cause of hip pain, but MR imaging of the hip has a deﬁnite role
in excluding or conﬁrming differential diagnoses, for example, AVN,
which is described below. MRI arthrography may have a speciﬁc
role to help diagnose a labral tear, for which it is the ﬁrst-line im-
aging of choice23, or in younger patients, typically aged between 25
and 50, who may have femoro-acetabular impingement (FAI)
syndrome, although there is ongoing controversy over this condi-
tion24. In these younger patients, in whom an XR may frequently
demonstrate only subtle changes or signs of minimal OA or even be
reported as normal, but who have symptoms originating from the
hip joint, FAImay be a key differential diagnosis to early OA, andMR
arthrography has been suggested as a helpful test to conﬁrm a
diagnosis of FAI25.CT in the diagnosis of OA
Like MRI, CT can offer 3D imaging of a joint compared with the
traditional 2D imaging provided by XR. CT has advantages over MRI
of being cheaper, more widely available and having much faster
scan acquisition times, but does involve ionising radiation. When
used to image peripheral joints, such as the hand or knee, the ra-
diation dose is lower than background annual radiation dose26. CT
may have a role in conﬁrming a diagnosis of OA of the hip, if the
clinical picture or XR are non-diagnostic, particularly as the infer-
oposterior and posterolateral hip joint frequently demonstrate
osteophytes and loss of joint space, and this region is not clearly
visualised on a standard anteroposterior XR27. CT can demonstrate
calciﬁed cartilage, the subchondral bone plate and trabecular sub-
chondral bone26, and may offer improved visualisation of sub-
chondral bone cysts and osteophytes compared with MRI or XR28
and may have a role in aiding pre-surgical operation planning in
speciﬁc individual cases.
In the research setting, 3D segmentation and analysis tools have
been developed to examine the subchondral bone texture and bone
mineral density within the knee26, which is of particular interest in
understanding the structure of bone marrow lesions, not least
because of their associations with pain and progression of OA. A
new CT grading system for hip OA has recently been proposed and
shows substantial reproducibility28 which may be of future clinical
use. The authors also suggest that CT-detected femoral osteophytes
may be a future reliable imaging biomarker of OA.Imaging features and association with symptoms
There are many publications assessing the structure-symptom
association in peripheral joint OA. It is worth noting that the
severity of XR features, the most commonly used imaging tech-
nique in OA, may be discordant with a person's symptoms, partly
due to intra-articular sources of joint painwhich are not seen on XR
(such as bone marrow lesions and synovitis) and because an XR
cannot assess for extra-articular features of pain, for example
bursitis around the knee or hip joints. Whilst speciﬁc ultrasound
and MRI features have been associated with symptoms, this has
been reviewed extensively elsewhere22,29e37.Using imaging to monitor progression of OA
Structural modifying drugs remain elusive in OA and XRs are
insensitive to structural change over time38, hence why in clinical
practice, serial imaging to monitor structural change is not often
needed, unless to answer speciﬁc clinical questions, for example, if
a patient's symptoms have worsened and a new or additional
diagnosis is being considered. A repeat XR may be of help before
considering a surgical referral, for example for total joint replace-
ment, but the UK NICE guidance suggests that a person with OA
should be referred for a surgical opinion if they have signiﬁcant
pain and structural impairment, and not on the basis of the XR
severity of joint damage39.
Measurement of JSN in the knee remains the gold standard for
assessing a potential disease modifying drug in clinical trials, but it
has recognised limitations. JSN was thought to represent a surro-
gate marker of cartilage loss, but in the knee, this has been shown
to also represent meniscal degeneration and extrusion40, hence the
utility of JSN as a marker of cartilage loss is complex, even in the
clinical trial setting. Furthermore, any cartilage defects, for example
in the non-weight bearing portion of the posterior femur, will not
affect the joint space width seen on a plain ﬁlm of the knee41.
Measuring JSN can detect a change over long time periods time, but
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the knee, which is not performed outside of the research setting.
Semi-quantitative scoring tools have been developed for
assessing change within the OA joint using both MRI and ultra-
sound imaging. There are now some reports of reliability in hand
and knee semi-quantitative scoring systems using ultrasound42,43.
There are several MRI semi-quantitative scoring systems which are
used to describe pathological changes within the knee (MRI Oste-
oarthritis Knee Score)44, hand (Oslo Hand OA MRI score)45 and the
Hip Osteoarthritis MRI and the Hip Inﬂammation MRI scoring
systems46, which have been used both longitudinally and cross-
sectionally to describe changes within the joints, and have been
applied as secondary outcome measures in clinical trials47. Given
the complexity of these semi-quantitative scores and their current
lack of clinical utility (for example, lack of evidence for clinical
importance in change in any of the pathologies assessed)47,48, they
currently remain for use in the research setting only. Quantitative
cartilage assessments in the knee have been used reliably and
responsively in OA clinical trials, but again this technology is not
ready for application in routine clinical practice, partly due to the
time required for such assessments and partly because there are, as
yet, no disease modifying drugs available in practice which may
slow or halt any detected cartilage loss.
Using imaging to examine differential diagnoses of OA e when to
image and with what modality?
Differentiating mechanical from inﬂammatory joint disease
Secondary OA is common in people with an underlying in-
ﬂammatory arthritis and new inﬂammatory arthritis may present
in a patient with known OA. It is important to attempt to differ-
entiate whether symptoms are due to the OA or the inﬂammatory
disease in order to determine the treatment plan accordingly. There
are new EULAR/ACR criteria for the diagnosis of rheumatoid
arthritis that allow utilisation of MRI or ultrasound in the assess-
ment in the number of involved joints49.
Features in the history that may indicate an inﬂammatory
arthritis include prolonged morning stiffness (>60 min) or diseases
that are associated with an inﬂammatory arthritis (including pso-
riasis or inﬂammatory bowel disease). Clinical examination should
include the pattern of joint involvement, presence of Heberden or
Bouchard nodes, crepitus and effusions. Raised inﬂammatory
markers and positive antibody tests (e.g., anti-cyclical citrullinated
peptide or rheumatoid factor) aid in diagnosis of inﬂammatory
arthritis.
XR imaging may indicate characteristic changes of OA but may
also demonstrate a pattern of erosive change more characteristic of
an inﬂammatory arthritis (enabling differentiation of rheumatoid
arthritis, psoriatic arthritis and gout). XR would be the ﬁrst imaging
modality requested. Ultrasound imaging may be helpful, particu-
larly in the hands, using power Doppler technique. Whilst grey
scale synovitis and joint effusion are common in hand OA34,36,
particularly in erosive OA, power Doppler signal is more commonly
indicative of an inﬂammatory arthritis50. Due to its multi-planar
acquisition, ultrasound may also be useful for identifying osteo-
phytes which may not be seen on a plain radiograph, indicating OA.
If there is concern that an inﬂammatory arthritis is present, both
ultrasound and MRI imaging have been shown to be more sensitive
than clinical examination in detecting inﬂammation and may be
used to conﬁrm the presence of an inﬂammatory arthritis.
Inﬂammation seen on imaging in inﬂammatory arthritis may be
more predictive of a therapeutic response to treatment and also
predicts future joint damage51. It should be noted that much of the
literature in this area involves assessment of small joints such as
hands and (to a lesser extent) forefeet.Whilst both ultrasound and MRI may be used to assess inﬂam-
mation (synovitis and osteitis) in RA and its response to therapy,
using these modalities to assess change in synovitis in OA remains
in the research setting. This is largely because there are few studies
that have assessed the response to anti-synovial therapies in OA,
most of which have failed to show a strong association between a
change in synovitis and a change in pain52e56, although one recent
study using methotrexate for painful knee OA did demonstrate a
reduction in both ultrasound-detected synovitis and pain57. A
greater volume of synovitis in OA does not appear to predict a
response to anti-synovial therapy, though the literature in this area
is growing. It has been suggested that increased power Doppler
may be associated with increased response to corticosteroid in
hand OA54. We have also noted that the response to intra-articular
corticosteroid in knee OA may reﬂect the change in synovial early
enhancement rate, assessed using contrast-enhanced dynamic
MRI58. This may be because these imaging measures better reﬂect
true inﬂammation. However lack of predictive value of the current
synovitis scoring systems may sometimes also reﬂect their semi-
quantitative nature.
Rapidly progressive osteoarthritis (RPOA)
The concept of a rapidly destructive joint disease was ﬁrst
described by Forestier in 1957 and was ﬁrst termed “rapidly
destructive arthrosis” in 197059,60. It has also been termed
“rapidly destructive hip disease”61 and “rapidly destructive cox-
arthrosis”62. There is no accepted deﬁnition of RPOA within the
published literature, which is limited to case reports or small case
series61e67.
The aetiology and incidence of RPOA remains unknown. The
incidence of progression of OA joints to RPOA varies greatly be-
tween 2 and 18% in case series60,68,69. Most commonly described in
the hip joint, where it may rarely be bilateral66, it is more common
in women than in men with an average age of onset of between 60
and 70 years.
Histology of excised hip joints which have demonstrated rapid
joint destruction shows areas of extensive fracture and callus for-
mation and necrosis, suggesting that osteonecrosis may occur
secondary to pre-existing OA and subchondral fracture64,70.
Ischaemia and ﬁbrosis of the subchondral bone and pseudogranu-
lomatous lesions have also been described64,70,71. It has been
recently suggested that RPOA is the result of secondary osteonec-
rosis after subchondral fracture72, but the cause of the rapid
chondrolysis (seen as a rapid reduction in joint space on XR) is not
known64.
RPOA has been of increasing interest recently due to cases of
RPOA in patients using concomitant non-steroidal anti-inﬂamma-
tory drugs (NSAIDS) whilst undergoing clinical trials with anti-
nerve growth factor antibodies, such as tanezumab73e75. One
possiblemechanism for this is “analgesic joint”, a concept originally
described after cases of rapid progression of OA in patients taking
NSAIDs, although the role of NSAIDs has been refuted76. The hy-
pothesis is that the pain improvement gained from effective anal-
gesia resulted in increased activity and weight-bearing; patients
with a more atrophic OA phenotype, or with an increased suscep-
tibility to subchondral fracture, may be more at risk of RPOA due to
increased mechanical overloading of the hip joint. Furthermore,
NSAIDs impair bone healing77.
In clinical practice, the term RPOA may be used to describe a
rapid clinical deterioration and radiographic progression of a joint,
oftenwith total obliteration of the joint space and joint destruction
occurring within a few months. Patients complain of rapidly
increasing joint pain with restriction of movement62,64. Due to the
rapidity and potential severity of symptoms, differential diagnoses
may include crystal arthritis, sepsis and primary osteonecrosis.
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presentation. Lequesne suggested a deﬁnition of RPOA of >2 mm
joint space loss or 50% JSN within a year59, but changes have been
described as rapidly as within 6weeks61. A consistent ﬁnding across
case series is that osteophytosis is usually mild62e64 and the
chondrolysis generally affects the superolateral part of the hip joint.
After the initial chondrolysis, there is rapid atrophic bone
destruction within both the femoral head and the acetabulum.
There has been only limited MR imaging of RPOA64,70. Synovitis
and bone marrow lesions, ﬂattening of the femoral head and cyst-
like subchondral defects are commonly described, with only small
osteophytes noted. Subchondral fractures were noted in a third of
the largest case series64. There are no speciﬁc MRI features that can
deﬁne RPOA, but MRI may be useful in differentiating, for example,
from localised AVN of the femoral head.AVN of the femoral head
AVN of the femoral head, is a condition resulting from disrup-
tion of the vascular supply to the femoral head, with subsequent
localised hypoxia78. The underlying mechanism of osteocyte death
and increased osteoclast activity which causes thinning and
resorption of subchondral trabeculae, is probably due to
apoptosis79. A sclerotic rim surrounds the localised area of bone
necrosis and with repetitive weight-bearing, there is subsequent
trabecular collapse and the resulting subchondral fracture may be
seen on XR with the characteristic “crescent sign” (Fig. 3). Further
weight-bearing leads to subchondral collapse.
The incidence of non-traumatic AVN of the femoral head has
recently been estimated at 2.5 cases per 100,000 person-years80.
This condition affects menmore commonly thanwomen and it may
be bilateral in up to 75% of cases81. Common causes include pro-
longed corticosteroid use, alcohol excess, hip trauma or previous
surgery. Other associated conditions include smoking, pancreatitis,
SLE or other connective tissue diseases, coagulopathy and HIV78.
Patients are usually under the age of 50, compared with the
mean older age of presentation of RPOA, and generally present with
increasing pain, which is worse with weight-bearing and improved
with rest78. Pain from the hip joint is often felt in the groin but may
also present in the anterior thigh or buttocks. On clinical exami-
nation, there may be limitation of internal rotation or abduction of
the hip. Such symptoms in a young person, particularly if the XR is
normal and they have any risk factors for AVN, should trigger
further investigation for possible osteonecrosis.Fig. 3. XR of the left shoulder demonstrating AVN of the humeral head. Note the
radiolucent crescent parallel to the articular surface (arrowed), secondary to sub-
chondral structural collapse of the necrotic segment.Imaging ﬁndings. Radiographs of both hips are the ﬁrst-line imag-
ing investigation for possible AVN of the femoral head. A frog leg
view, in addition to the standard AP view, may demonstrate sub-
chondral collapse. There are various XR classiﬁcation systems for
AVN of the femoral head, beginning with a normal XR, progressing
to sclerosis, subchondral collapse with or without femoral head
ﬂattening and ﬁnally marked degenerate changes with osteophy-
tosis. XRs may be normal in the early stages, so MR imaging should
be considered in a patient with hip pain in whom the XR is normal,
particularly if clinical risk factors for AVN is present (Fig. 4).
MRI is both sensitive and speciﬁc for AVN and can be used to
judge the location and volume of bone involved81. MRI classiﬁca-
tion may include the Mitchell classiﬁcation system but this is not
routinely used in clinical practice. The earliest ﬁnding is of a non-
speciﬁc focal area of intermediate signal, on T1 weighted and
high signal intensity on T2 weighted images, representing apparent
marrow oedema. This then rapidly progresses to the well deﬁned
pattern characteristic of AVN, with a serpentine (snake-like) low
signal intensity rim which develops in over 90% of cases of AVN,
seen on both T1 and T2 weighted images (Fig. 5). This rim repre-
sents the interface between reactive bone and the necrotic area81.
Other characteristic MR ﬁndings include a high signal intensity line
present on T2 weighted images, seen just inside the low signal
intensity serpentine line; this is the “double-line sign.”
There is little recent data with regards to the use of CT in
assessing possible AVN, as it is known to be insensitive compared to
MRI for detecting early change82,83, although CT has been shown to
reveal more subchondral fractures complicating AVN than either
XR or MRI84. CT may rarely be considered as an imaging option in a
situation where MRI is not available and if the XR is not diagnostic
(CT may show femoral head subchondral collapse that is not seen
on XR), but such cases should ideally be discussed on an individual
basis with a radiologist.SIF
SIF occur in bone unable to withstand normal activity and by
deﬁnition should not be the result of trauma85. SIF have been
described in the knee and the humeral and femoral heads70,86e88
and are an uncommon cause of rapid onset pain and arthritis,
most commonly in older women. There is some disagreement
within the published literature as to whether spontaneous osteo-
necrosis of the knee (SONK) is an individual entity or represents SIF
within the knee, with secondary osteonecrotic changes. It appears
that SIF may have been previously misdiagnosed as SONK, asFig. 4. AVN of the femoral head. XR image of the pelvis demonstrating AVN of the right
femoral head. Note the ﬂattening of the femoral head (dotted arrow), sclerosis of the
acetabular margins (solid arrow) and subchondral cysts.
Fig. 5. T1 weighted coronal MRI image demonstrating AVN of the right femoral head.
Note the serpentine areas (arrowed) and double line sign.
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most common histological changes in SONK are osteoporosis89 and
SIF86,90. Thus it appears that SONK may represent insufﬁciency
fractures, and any necrosis is a secondary phenomenon.
The prevalence of SIF in the femoral head has been assessed in a
large cohort of almost 8000 femoral heads, removed for a diagnosis
of OA or osteonecrosis. SIF were seen in 6% of histological exami-
nation of OA femoral heads and 11% of osteonecrotic heads91.
Insufﬁciency fractures in the knee are usually described in
elderly women with sudden onset pain, usually in the medial side
of the knee, which is commonly the only joint involved92, with no
previous history of trauma. There is a high prevalence of associated
meniscal tears and the weight bearing articular surface of the
medial femoral condyle is most commonly affected85.
SIF in the femoral head has been reported both unilaterally and
bilaterally87, usually presenting with rapid onset pain. Whilst SIF
have been reported after prolonged weight-bearing exercise (in
military recruits)93, there should be no history of trauma. SIF may
be difﬁcult to differentiate clinically from AVN as both present with
rapid onset pain, although those with SIF are usually older. How-
ever a recent publication suggests that in the presence of femoral
head collapse on XR, being of female sex, aged over 70, with a
history of osteoporosis and with no history of corticosteroid use or
alcohol abuse, increases the likelihood of the diagnosis of SIF rather
than AVN94.Fig. 6. SIF of the knee (previously termed “SONK”). MRI (STIR sequence) image of the
knee demonstrating widespread bone marrow oedema (black arrow) within the
medial femoral condyle and a medial meniscal tear. The subchondral crescent indicates
the fracture line (white arrow).Imaging ﬁndings. Radiographs within the ﬁrst couple of months of
the initial symptoms, are often normal, other than demonstrating
age-related OA. There may be sclerosis at the fracture line, due to
localised trabecular collapse. At a later stage, XRs may demonstrate
collapse of the femoral head or ﬂattening of the weight-bearing
segment of the medial femoral epicondyle. While CT can demon-
strate subchondral fractures82 and, in a small study, identiﬁed
insufﬁciency fractures when the XR was normal95, in our experi-
ence, it is very rarely used. If warranted clinically, additional MR
imaging will demonstrate a diffuse bone marrow lesion, with the
insufﬁciency fracture seen as a low intensity band beneath the
articular cartilage on T-1 weighted images. This corresponds his-
tologically to the fracture line96. SIF and AVN of the femoral head
may have similar clinical and XR characteristics but it has been
suggested that they can be differentiated by differingcharacteristics of this band on MRI97, although this is not in routine
use in clinical practice.
MR imaging of the knee may demonstrate a diffuse high in-
tensity bone marrow lesion without the peripheral low signal in-
tensity rim (as seen in osteonecrosis), with a focal area of low signal
intensity adjacent to the subchondral bone plate85 (Fig. 6). It has
been suggested in the past this represents focal osteonecrosis
(hence the previous terminology SONK), but the appearances are in
keeping with SIF and most musculoskeletal radiologists believe
that this is the case. As most SIF within the knee occur in elderly
women who already have OA, in reality it can be difﬁcult to
differentiate between bonemarrow lesions and sclerosis secondary
to OA, and changes secondary to a possible SIF. Hence imaging of
the knee may not be helpful and this should be noted when
requesting imaging for a patient.CPPD and gout
Calcium pyrophosphate deposition (CPPD) has previously
been termed calcium pyrophosphate deposition disease, but this
term is inaccurate as crystal deposition may be entirely asymp-
tomatic. The term “pseudogout” is also best avoided as this can
confuse patients.
Whilst it can be asymptomatic, it is also the third most common
inﬂammatory arthritis98. It has a predilection for joints with un-
derlying OA; patients with OA are three times more likely to have
CPPD99. Ageing is a major risk factor, with this condition being rare
in those under ﬁfty. Other risk factors for CPPD are previous joint
trauma, a positive family history and metabolic disorders such as
hypomagnesaemia, haemochromatosis or hyperparathyroidism.
The knee is the most common site for CPPD100.
Calcium pyrophosphate crystals are the most common cause of
chondrocalcinosis, although basic calcium phosphate crystals,
although less common, are another cause. However, chon-
drocalcinosis is a radiographic diagnosis and the deﬁnitive diag-
nosis of CPPD arthritis relies on the detection of calcium
pyrophosphate crystals in the synovial ﬂuid or on histology101.
CPPD may present as an acute arthritis with rapid onset of pain,
swelling, tenderness and often redness of the joint, most commonly
Fig. 7. XR of the knee demonstrating chondrocalcinosis (arrowed) in both lateral and
medial tibio-femoral compartments.
C.Y.J. Wenham et al. / Osteoarthritis and Cartilage 22 (2014) 1692e17021698in an older patient with known osteoarthritis. The knee is most
commonly affected100,102, but other joints such as the wrist and
elbow may also be involved. The main differential diagnoses are
gout or septic arthritis, and the deﬁnitive investigation is aspiration
and microscopy and culture of the synovial ﬂuid.
CPPD may also present as a chronic inﬂammatory arthritis; the
majority are a mono or oligoarthritis and inﬂammatory markers
may be raised100. Chronic swelling of the knees and/or wrists in an
older person should prompt needle aspiration of the joint to look
for CPP crystals.Fig. 8. There is chondrocalcinosis within the triangular ﬁbrocartilage bilaterally (solid arrow
metacarpal joints (dotted arrows), with relatively less involvement of the thumb bases andImaging ﬁndings. CPPD is the most common cause of chondrocalci-
nosis (Figs. 7 and 8) and can be detected on both XR and US imaging,
however the percentage of patients with chondrocalcinosis who
haveCPP crystals in their synovialﬂuid varies greatly, henceanormal
XR does not exclude the diagnosis of CPPD. This variation may be
because CPP crystals are small and only weakly, or non-birefringent
on microscopy and therefore harder to detect, or because basic cal-
cium phosphates can also cause chondrocalcinosis101. In clinical
practice, using imaging to identify chondrocalcinosis may be helpful
for determining the cause of a chronic inﬂammatory arthritis as it is
less likely to occur with rheumatoid arthritis, and strongly points
towards CPPD103. An XR of an acute monoarthritis with a history
compatible with crystal arthritis is usually not required as it is un-
likely to change the patient's management, as the absence of chon-
drocalcinosis does not exclude CPPD.
The main differential for CPPD is gout, due to deposition of
monosodiumurate crystals within the soft tissues or joint, resulting
in acute or chronic inﬂammation. Both XRs and US can help conﬁrm
a diagnosis of gout if there is clinical uncertainty. Classic gouty
erosions may be seen on XR, and ultrasound may detect erosions
not noted on XR, which are characteristically broad-based with
overhanging margins, seen in a peri-articular location. In chronic
gout, soft tissue crystal deposition is common and may be seen on
the extensor surface of the knees and elbows and on the ulna aspect
of the wrist and hand. Ultrasound may conﬁrm the presence of
these gouty tophi, which are hyperechoic, in contrast to rheuma-
toid nodules, which are hypoechoic. Tendon involvement may be
seen extending from a subcutaneous gouty tophus along the sub-
stance of the tendon104.
There is interest in the role of ultrasound in detecting calciﬁ-
cation in knees, although studies are relatively few. US appears both
sensitive (validity 0.87, 95% CI 0.69e1.04) and speciﬁc (validity 0.96,
95% CI 0.9e1.03) for detecting CPP crystals in the synovial ﬂuid105
and positive ultrasound ﬁndings can be strongly supportive of the
diagnosis of CPPD.s). Note the atypical pattern of osteoarthritis, with changes affecting the radiocarpal and
interphalangeal joints. This atypical pattern of OA is typical for CPPD disease.
Fig. 9. Transverse view of the distal humerus in a patient presenting with acute gout in
the elbow joint. Note the “double-contour sign” (dotted arrow) due to urate crystal
deposition on the surface of the articular cartilage.
C.Y.J. Wenham et al. / Osteoarthritis and Cartilage 22 (2014) 1692e1702 1699Ultrasound may be helpful to differentiate between gout and
CPPD as the distribution of crystals within the joint is different,
with gout demonstrating the “double-contour sign” (Fig. 9) of urate
crystals deposited on the cartilage surface, whilst CPPD tends to
demonstrate crystals within rather than on the surface of the
articular cartilage. US may be more sensitive than XR in identifying
CPPD106. Ultrasound may have a role in diagnosis in a clinical case
which does not have a classical presentation, or in whom synovial
ﬂuid aspiration is difﬁcult or unsuccessful. However, it cannot
accurately access deeper joints and the current published data is
limited.
Conclusion
OA is largely a clinical diagnosis and imaging should be reserved
for when an alternative diagnosis is being considered. The advan-
tages and limitations of each type of imaging should be considered
before selecting an individual modality. In patients with a rapid
onset of, or sudden severe symptoms in the knee or hip, a thorough
clinical history, for example, establishing the presence or absence of
risk factors for osteonecrosis, a history of osteoporosis or trauma,
may point to an alternative diagnosis, whereby selecting the correct
imaging modality, usually MRI, will enable the diagnosis to be
made.
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